Safety, tolerability and immunogenicity of PRV-101, a multivalent vaccine targeting coxsackie B viruses (CVBs) associated with type 1 diabetes: a double-blind randomised placebo-controlled Phase I trial
Article in Diabetologia (February 2024)
The most recent citing publications are shown below. View all 44 publications that cite this research output on Dimensions.
Article in Diabetologia (February 2024)
Article in International Journal of Molecular Sciences (February 2024)
Article in Antiviral Research (December 2023)